
Reference data for this compound is being added. Every lot still ships with its third-party Certificate of Analysis.
Contents Survodutide Form / storage Lyophilized powder; store at −20 °C, protect from light Purity ≥98% — see lot COA CAS 2805997-46-8 Molecular formula C192H289N47O61 Molecular weight 4231.63 g/mol Testing Identity (UV/Vis λmax), purity, assay (Beer-Lambert), heavy metals, microbial (TAMC/TYMC) COA Batch-specific — view on this page Research background Survodutide is a synthetic, acylated analog built on the human glucagon sequence (rather than oxyntomodulin), designed to engage both the glucagon receptor (GCGR) and the GLP-1 receptor. A non-coded amino-acid substitution improves proteolytic stability and a C18 fatty-acid moiety promotes albumin binding. Research interest centers on how balanced glucagon/GLP-1 co-agonism affects energy expenditure, hepatic metabolism, and glucose handling in preclinical models, and on its mechanistic distinction from GIP-containing co-agonists. Research applications Tool compound for glucagon/GLP-1 receptor dual-signaling assays Preclinical models of energy expenditure and hepatic metabolism Comparator in glucagon-based vs. oxyntomodulin-based co-agonist research Quality & documentation Every lot is tested by an independent third-party laboratory before it enters the catalog.
Purity is measured per lot; panel results per the Analytical Formulations summary report for the lot currently shipping.